Showing results (391-400 of 626) with videos related to
Sort By:
Pageof 63
Frontiers in Cardiovascular Medicine|May 31, 2021
Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 PatientsGuido Iaccarino, Guido Grassi, Claudio Borghi, et al.World Journal of Stem Cells|June 17, 2021
Role of induced pluripotent stem cells in diagnostic cardiologySteven B Karch, Vittorio Fineschi, Pietro Francia, et al.Journal of Hypertension|June 15, 2007
Blood pressure control in Italy: results of recent surveys on hypertensionMassimo Volpe, Giuliano Tocci, Bruno Trimarco, et al.Journal of Hypertension|January 27, 2012
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?Massimo Volpe, A H Jan Danser, Joël Menard, et al.Aging Clinical and Experimental Research|December 5, 2009
Decreased nocturnal systolic blood pressure fall in older subjects with depressionAngelo Scuteri, Gianfranco Spalletta, Marcello Cangelosi, et al.European Heart Journal|May 25, 2013
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass graftingEmiliano Angeloni, Francesco Paneni, Ulf Landmesser, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 18, 2026
Hypertension Treatment with Angiotensin Receptor Blockers and Other Antihypertensive Agents: A Real-World Registry from a High-Volume Specialized Center Over TwoDecadesGiuliano Tocci, Giulia Nardoianni, Barbara Pala, et al.Journal of Cardiovascular Electrophysiology|May 22, 2020
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathyCarmen Adduci, Francesca Boldini, Francesca Palano, et al.Minerva Cardiology and Angiology|November 2, 2022
Lipoprotein(a) and the risk of recurrent events in patients with acute myocardial infarction treated by percutaneous coronary interventionStefano Rigattieri, Ernesto Cristiano, Federica Tempestini, et al.Journal of Interventional Cardiology|July 5, 2021
Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized TrialsStefano Rigattieri, Ernesto Cristiano, Francesca Giovannelli, et al.Pageof 63